{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:09:46Z","timestamp":1791727786149,"version":"4.3.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Carbapenemase-producing\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      (CPKP) is a major cause of nosocomial infections in children, with high mortality. This study compared clinical features and outcomes between CPKP and carbapenem-susceptible\n                      <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                      (CSKP) infections in pediatric patients and identified independent risk factors for carbapenem resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort study included pediatric patients with confirmed\n                      <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                      infections at a university hospital. Patients were categorized into CPKP and CSKP groups. Data on demographics, clinical features and laboratory results were analyzed. Univariate and multivariate logistic regression analyses were performed to identify risk factors for carbapenem resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The CPKP group had significantly higher 30-day mortality (29.7% vs. 13.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.019), longer hospital stay (14 vs. 10 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and prolonged intensive care unit stay (3 vs. 0 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) compared to CSKP. CRP levels were significantly elevated in CPKP patients (141 vs. 51\u2009mg\/L,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), with a cutoff of 110\u2009mg\/L showing moderate predictive value (area under the curve: 0.699). Multivariate analysis identified prior fluoroquinolone use (odds ratio [OR]: 3.09, 95% confidence interval [CI]: 1.22\u20137.83), previous CPKP colonization\/infection (OR: 7.89, 95% CI: 2.92\u201321.36), recent surgery (OR: 4.76, 95% CI: 1.89\u201312.02) and inotropic support requirement (OR: 3.27, 95% CI: 1.21\u20138.83) as independent risk factors. Chemotherapy, immunotherapy, use of invasive devices other than central venous catheters, polymicrobial sepsis, underlying illnesses and site or type of infection were evaluated but did not show a statistically significant association with carbapenem resistance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>CPKP infection in pediatric patients was associated with poor outcomes and was independently related to prior fluoroquinolone use, recent surgery, previous CPKP colonization or infection, and illness severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005182","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:00:30Z","timestamp":1771390830000},"page":"711-717","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical, Laboratory and Prognostic Features of Nosocomial Infections Caused by Carbapenemase-producing Klebsiella pneumoniae in Pediatric Patients"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-7607","authenticated-orcid":false,"given":"Tu\u011f\u00e7e","family":"Tural Kara","sequence":"first","affiliation":[{"name":"From the Department of Pediatric Infectious Diseases, Faculty of Medicine, Akdeniz University, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe K\u00fcbra","family":"A\u00e7ik","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Infectious Diseases, Faculty of Medicine, Akdeniz University, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Tekeli","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Infectious Diseases, Faculty of Medicine, Akdeniz University, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Burcu","family":"\u00c7a\u011flar Kizil","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Infectious Diseases, Faculty of Medicine, Akdeniz University, Antalya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"127839","DOI":"10.1016\/j.micres.2024.127839","article-title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat.","volume":"288","author":"Lei","year":"2024","journal-title":"Microbiol Res"},{"key":"R2-20260706","first-page":"e81902","article-title":"Temporal trends in the management and mortality associated with Klebsiella pneumoniae carbapenemase-producing enterobacterales: a cohort study.","volume":"17","author":"Pinto","year":"2025","journal-title":"Cureus"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"FSO438","DOI":"10.2144\/fsoa-2019-0098","article-title":"A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options.","volume":"6","author":"Elshamy","year":"2020","journal-title":"Future Sci OA"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/antibiotics13111017","article-title":"Benefits and safety of empiric antibiotic treatment active against CPKP-producing Klebsiella pneumoniae for febrile neutropenic episodes in colonized children with acute leukemia\u2014an 8-year retrospective observational study.","volume":"13","author":"Micozzi","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkad262","article-title":"Mortality in CPKP-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.","volume":"78","author":"Giacobbe","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/ice.2017.197","article-title":"Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis.","volume":"38","author":"Kohler","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/mdr.2018.0339","article-title":"Infections caused by carbapenemase-producing Klebsiella pneumoniae: microbiological characteristics and risk factors.","volume":"25","author":"Pan","year":"2019","journal-title":"Microb Drug Resist"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/antibiotics12050796","article-title":"The prevalence of carbapenemase-producing microorganisms and use of novel cephalosporins for the treatment of severe infections caused by carbapenem-resistant gram-negative bacteria in a pediatric cardiac intensive care unit.","volume":"12","author":"Tripiciano","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1080\/14656566.2019.1660772","article-title":"The latest advances in \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections.","volume":"20","author":"Papp-Wallace","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/INF.0000000000002176","article-title":"A multi-centered case-case-control study of factors associated with Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae infections in children and young adults.","volume":"38","author":"Logan","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis.","volume":"11","author":"Lin","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fcimb.2020.00462","article-title":"Epidemiology and risk factors for carbapenem-resistant Klebsiella pneumoniae and subsequent MALDI-TOF MS as a tool to cluster CPKP-2-producing Klebsiella pneumonia: a retrospective study.","volume":"10","author":"Fang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.","volume":"30","author":"Gasink","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"1499057","DOI":"10.3389\/fmed.2025.1499057","article-title":"Comparative analysis of clinical characteristics and outcomes between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae infections: insights from a tertiary hospital in Northern China.","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jac\/dkm356","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.","volume":"60","author":"Falagas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1086\/605922","article-title":"Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.","volume":"30","author":"Borer","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R17-20260706","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl_1","key":"R18-20260706","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace.","volume":"215","author":"Logan","year":"2017","journal-title":"J Infect Dis"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/antibiotics14080825","article-title":"Lessons from four years (2021-2024) of Klebsiella pneumoniae resistance surveillance epidemiological trends in a Romanian intensive care unit.","volume":"14","author":"Sava","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.diagmicrobio.2013.06.007","article-title":"CPKP-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.","volume":"77","author":"Papadimitriou-Olivgeris","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"e0197021","DOI":"10.1128\/spectrum.01970-21","article-title":"Association between timing of colonization and risk of developing Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infection in hospitalized patients.","volume":"10","author":"Cano","year":"2022","journal-title":"Microbiol Spectr"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/antibiotics14090866","article-title":"Impact of the COVID-19 pandemic on carbapenem-resistant Klebsiella pneumoniae in Northern Brazil: a shift toward NDM producers.","volume":"14","author":"Barros","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae.","volume":"16","author":"Xu","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.diagmicrobio.2010.10.013","article-title":"Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.","volume":"69","author":"Neuner","year":"2011","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:00:15Z","timestamp":1783328415000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005182","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}